Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco:: a prospective longitudinal cohort study
Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco:: a prospective longitudinal cohort study
复制标题
DOI:
10.1016/s0140-6736(08)60135-x
复制
发表时间:
2008-01-19
期刊:
影响因子:
168.9
通讯作者:
Kilian, Mogens
中科院分区:
文献类型:
--
作者:
Haubek, Dorte;Ennibi, Oum-Keltoum;Kilian, Mogens
Background Periodontitis is a loss of supporting connective tissue and alveolar bone around teeth, and if it occurs in an aggressive form it can lead to tooth loss before the age of 20 years. Although the cause of periodontitis in general remains elusive, a particular clone (JP2) of the gram-negative rod Aggregatibacter (Actinobacillus) actinomycetemcomitans is considered a possible aetiological agent of the aggressive form in adolescents living in or originating from north and west Africa, where the disease is highly prevalent. We did a population-based longitudinal study of adolescents to assess the role of the JP2 clone in the initiation of aggressive periodontitis.Methods A total of 700 adolescents from public schools in Rabat, Morocco, were enrolled in the study. We used PCR to detect A actinomycetemcomitans in plaque samples (taken from molar and incisor sites) and to differentiate between the JP2 clone and other non-JP2 genotypes of the bacterium. 18 individuals were found to already have periodontitis and were excluded. The 682 periodontally healthy adolescents (mean age 12.5 years; SD 1 . 0) were classified according to their A actinomycetemcomitans carrier status at baseline. After 2 years, 428 (62. 8%) individuals returned for re-examination, which included recording of periodontal attachment loss measured from the cemento-enamel junction to the bottom of the periodontal pockets of all teeth present.Findings Individuals who carried the JP2 clone of A actinomycetemcomitans alone (relative risk 18 . 0; 95% CI 7.8-41.2, p